[Federal Register Volume 84, Number 214 (Tuesday, November 5, 2019)]
[Notices]
[Page 59646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24108]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-527]


Bulk Manufacturer of Controlled Substances Application: Halo 
Pharmaceuticals, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before January 6, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on July 19, 2019, Halo Pharmaceutical Inc., 30 North 
Jefferson Road, Whippany, New Jersey 07981-1030 applied to be 
registered as a bulk manufacturer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Dihydromorphine.........................    9145  I
Hydromorphone...........................    9150  II
------------------------------------------------------------------------

    The company plans to manufacture Hydromorphone (9150) for 
distribution to its customers. Dihydromorphone (9145) is an 
intermediate in the manufacture of Hydromorphone and is not for 
commercial distribution.

    Dated: October 22, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-24108 Filed 11-4-19; 8:45 am]
BILLING CODE 4410-09-P